CluePoints, provider of leading statistical and AI-driven software solutions, has welcomed publication of its research providing quantitative evidence on the financial value of risk-based quality ...
MORRISVILLE, N.C., May 19, 2026 (GLOBE NEWSWIRE) -- Science 37 today announced the publication of a new analysis in Applied Clinical Trials in collaboration with the Tufts Center for the Study of Drug ...
Drug developers plan to improve R&D management and operations in 2015 in order to cut development costs and avoid the glare of payers increasingly intent on containing drug prices, the Tufts Center ...
NOTTINGHAM, England--(BUSINESS WIRE)--Tufts Center for the Study of Drug Development (CSDD) today published a white paper sharing study results that indicate Quotient Sciences’ Translational ...
Dublin, Oct. 24, 2024 (GLOBE NEWSWIRE) -- The "Understanding the Implications of the New Directive on Corporate Sustainability Due Diligence (CSDD) Training Course" training has been added to ...
New research demonstrates RBQM-enabled trials achieve up to 23x ROI and 19% shorter phase durations, providing the industry's first quantitative business case for risk-based oversight in clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results